Showing results (261-270 of 289) with videos related to
Sort By:
Pageof 29
Translational Psychiatry|August 20, 2014
Dysfunctional dopaminergic neurotransmission in asocial BTBR miceM Squillace, L Dodero, M Federici, et al.Scientific Reports|March 13, 2015
Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate releaseRobert Nisticò, Fulvio Florenzano, Dalila Mango, et al.Ageing Research Reviews|December 16, 2022
Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer's disease: relevance for precision medicine in neurodegenerative diseasesSimone Lista, Andrea Vergallo, Stefan J Teipel, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2013
Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosisFrancesco Mori, Silvia Rossi, Sonia Piccinin, et al.Annals of Neurology|January 29, 2015
Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosisAlessandro Davoli, Viviana Greco, Alida Spalloni, et al.Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 25, 2019
Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recordingDomenico G Della Rocca, Maria Albanese, Fabio Placidi, et al.The European Journal of Neuroscience|November 1, 2011
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporterMaura Castelli, Mauro Federici, Silvia Rossi, et al.EMBO Molecular Medicine|December 16, 2018
RGS9-2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse modelsPaola Bonsi, Giulia Ponterio, Valentina Vanni, et al.Annals of Neurology|October 11, 2022
Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's DiseaseTommaso Schirinzi, Daniela Maftei, Francesco M Passali, et al.Neuromolecular Medicine|July 30, 2013
Interleukin-1β promotes long-term potentiation in patients with multiple sclerosisFrancesco Mori, Robert Nisticò, Georgia Mandolesi, et al.Pageof 29